Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Performance beat was driven by improved reimbursement rates, volume growth across all segments, and continued operational efficiencies from automation and AI efforts.
The company successfully concluded a four-year advocacy campaign in California, securing a significant pediatric private duty nursing rate increase effective January 1, 2027. Management is pivoting the labor strategy to proactively increase nurse wages in California this fall, aiming to capture pent-up demand and facilitate hospital discharges ahead of the formal rate implementation. The 'Preferred Payer' strategy is nearing completion across all segments, with 64% of PDS MCO volumes now under these agreements, up from 60% in Q1.
Home Health and Hospice growth was fueled by a strategic shift toward episodic care, which reached 81% of the mix, significantly improving margin profiles and clinical outcomes. The labor market is showing signs of stabilization, allowing the company to focus on cost-of-living adjustments rather than the 'catch-up' rate increases required over the past few years. Increased full-year 2026 revenue guidance to greater than $2.68 billion and adjusted EBITDA to greater than $365 million based on core organic strength.
Raised long-term organic growth targets for Private Duty Services to 5-6% and Home Health and Hospice to 8-10%, reflecting improved visibility into state and federal rate environments. Management expects to return Medical Solutions to double-digit growth by the beginning of 2027 as the preferred payer transition in that segment concludes. The M&A strategy is shifting toward 'Aveanna 2.0,' prioritizing Home Health and Hospice acquisitions to fill geographic gaps and leverage the company's existing back-office infrastructure.
Free cash flow is projected to remain strong at approximately $150 million for the full year, supporting a deleveraging path toward a sub-3x target by 2027. The Family First Homecare acquisition closed in June; The Family First Homecare integration is progressing nicely and as well or better than expected, with the majority of efforts expected to wrap up by late Q4. with back-office consolidation expected to wrap up by late Q4. Successfully repriced a term loan during Q2, reducing the interest rate by 75 basis points and lowering annual interest expense by approximately $10 million.
Substantially all variable rate debt ($1.4 billion) is now hedged with interest rate caps to mitigate SOFR exposure. Management noted that while the 'Big Beautiful Bill' (OBBBA) impacts Medicaid broadly, Private Duty Nursing remains insulated due to its significant cost-savings value proposition compared to NICU care. Nvidia-level potential. 30M+ investors trust Moby to find it first.
Extract — continue reading at the source.
